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Abstract
The prevalence of antibiotic resistance genes in pathogenic bacteria is a major challenge to treating many infectious
diseases. The spread of these genes is driven by the strong selection imposed by the use of antibacterial drugs. However, in
the absence of drug selection, antibiotic resistance genes impose a fitness cost, which can be ameliorated by compensatory
mutations. In Streptococcus pneumoniae, b-lactam resistance is caused by mutations in three penicillin-binding proteins,
PBP1a, PBP2x, and PBP2b, all of which are implicated in cell wall synthesis and the cell division cycle. We found that the
fitness cost and cell division defects conferred by pbp2b mutations (as determined by fitness competitive assays in vitro and
in vivo and fluorescence microscopy) were fully compensated by the acquisition of pbp2x and pbp1a mutations, apparently
by means of an increased stability and a consequent mislocalization of these protein mutants. Thus, these compensatory
combinations of pbp mutant alleles resulted in an increase in the level and spectrum of b-lactam resistance. This report
describes a direct correlation between antibiotic resistance increase and fitness cost compensation, both caused by the
same gene mutations acquired by horizontal transfer. The clinical origin of the pbp mutations suggests that this intergenic
compensatory process is involved in the persistence of b-lactam resistance among circulating strains. We propose that this
compensatory mechanism is relevant for b-lactam resistance evolution in Streptococcus pneumoniae.
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Introduction
Streptococcus pneumoniae is the causal agent of human infections
such as otitis, pneumonia and meningitis, which particularly affect
pediatric patients. Penicillin and other b-lactams (bLs) are the
treatmentsof choice foranypneumococcal infection.However, b-
lactam resistance has been growing steadily since the first clinical
resistant isolate was reported in the 1960s, with its dissemination
greatly threatening the clinical efficacy of these compounds [1].
bLs act by binding to the active sites of PBPs, which are involved
in peptidoglycan synthesis, thus altering the normal cell wall
formation and inducing cell death by lysis. Specifically, PBPs
catalyze the last two stages of peptidoglycan biosynthesis, namely
transglycosylation and transpeptidation. Its ability to uptake
exogenous DNA by induction of competence allows S. pneumoniae
to acquire antibiotic resistance mutations. b-lactam resistance
results from the acquisition of mutations within the pbp2b, pbp2x,
and pbp1a genes, causing multiple amino acid changes in PBP2b,
PBP2x, and PBP1a, which decrease the enzyme affinity for
bLs [2]. Exogenous DNA containing pbp mutations can be
provided by b-lactam resistant (bL
R) strains of S. pneumoniae or by
other Streptococcus species that cohabit the same niche, and
is incorporated into the chromosome by homologous
recombination [3].
TheriseinbL resistance detected amongcirculatingstrains isdue
to their ability to acquire pbp genes, as mentioned above, in
association with the wide therapeutic use of bL compounds, which
could act as a selective pressure [4]. In the absence of antibiotic
therapy, bacterial antibiotic resistance genes commonly result in
reduced fitness. Nevertheless, by acquiring intra or intergenic
compensatory mutations, certain clinical and laboratory strains are
able to restore this fitness cost [5,6]. Presumably, this compensation
allows these strains to compete with susceptible strains in their
natural niches. In S. pneumoniae, ciprofloxacin-resistant isolates have
a low prevalence due to a fitness cost imposed by point mutations in
the genes that encode DNA polymerase and DNA gyrase [7,8]. A
putative relationship has also been suggested between bL resistance
and the loss of virulence in pneumococcal clinical strains [9,10].
Likewise, Rieux and coworkers [11] described a loss of virulence in
single and double isogenic bL
R mutants, obtained by the
transformation of pbp2x and pbp2b mutations amplified from bL
R
clinical isolates. Related to this, Trzcinski and coworkers, studying
clinical isolates [12], reported an increase in fitness cost when bL
resistance was conferred by the pbp2b pbp2x pbp1a mutations
acquired by sequential transformation events.
In this work, we studied the clinical bL
R strains belonging to a
new serotype-14 variant of the Spain
9V-3 international clone. This
variant was isolated in Argentina and is indistinguishable by
PLoS Pathogens | www.plospathogens.org 1 February 2011 | Volume 7 | Issue 2 | e1002000MLST and sequence analysis of the cps genes from those isolated
in Baltimore, USA [13]. We demonstrated that the sequential
acquisition of pbp mutations to develop bL resistance is closely
associated to an intergenic compensatory process, which can
restores the fitness cost imposed by pbp2b mutations and may favor
the persistence and spread of bL resistance in S. pneumoniae.
Results
Fitness cost of b-lactam resistance in S. pneumoniae
The fitness cost imposed by pbp2b, pbp2x and pbp1a mutations
that confer bL resistance in S. pneumoniae was evaluated. These pbp
alleles were obtained from bL
R clinical strains that belonged to a
new serotype-14 variant of the Spain
9V-3 international clone,
identified and characterized in our laboratory [13]. To generate
strains bearing alleles of pbp2b, pbp2x, and pbp1a from clinical
strains that conferred resistance, we used PCR to amplify the DNA
region that encodes the transpeptidase domain of each mutated
pbp gene (in pbp1a, the glycosyltransferase domain was also
included; Fig. S1 in Supporting Information S1), where the bL
resistance mutations are commonly localized. These PCR
products containing the pbp mutations were introduced by
transformation into the bL-susceptible laboratory strain Cp1015,
and bL
R mutants were selected by growth on agar plates
supplemented with piperacillin for pbp2b, or with cefotaxime for
pbp2x and pbp1a (Table S1 in Supporting Information S2). The pbp
mutations were integrated into the chromosome by homologous
recombination.
Although no growth alterations for single pbp2x or pbp1a
mutants were found, which presented similar growth curves to that
of Cp1015, pbp2b mutants revealed an uncommonly prolonged
lag-phase (Fig. S2 in Supporting Information S1). Then, due to the
fact that clinical strains (from which pbp genes were amplified to
generate single pbp mutants) grew as well as the wild-type strain
(data not shown), we decided to investigate whether the fitness cost
resulting from pbp2b mutations was compensated for by associating
the pbp2x and pbp1a genes amplified from the same bL
R strain
donor of pbp2b. For this purpose, double and triple pbp mutants
were obtained by sequential transformation of single and double
pbp mutants (in that order), and the bL
R mutant selection was
made by using the MIC (Minimal Inhibitory Concentration)
increment produced by the acquisition of different pbp mutations
(Table 1). For example, a 14-fold increase occurred in the
piperacillin MIC level for the pbp2b mutant; a 10-fold increase was
found in the cefotaxime MIC level for the pbp2x or pbp1a mutants
(single or double pbp mutants), and a 14-fold increase resulted in
the cefotaxime MIC level for triple pbp mutants. The individual
and double pbp mutants displayed a transformation rate higher
than 10
22/mg of DNA, similar to the wild-type strain. Natural
competence was also assayed, but no alterations in spontaneous
transformability were detected (Fig. S3 in Supporting Information
S1). We observed a partial restitution of the growth curve for the
double pbp2b pbp2x and pbp2b pbp1a mutants, while a clear
restoration was found for the triple pbp mutant (Fig. S2 in
Supporting Information S1). Interestingly, all seven pbp2b mutants
constructed by transformation with different mutated pbp2b genes
obtained from other non-susceptible clinical isolates (Cba strains,
Table S1 in Supporting Information S2) and the Spain
9V-3 ATCC
strain displayed similar growth alterations (data not shown). These
pbp2b alleles were sequenced, and a comparison between them
revealed that the DNA sequences obtained from Cba-19, Cba-28,
Cba-52, Cba-62 and ATCC 700671 (clone Spain
9V-3) were
identical (Fig. S4 in Supporting Information S1). It was also found
that 5 amino acids were conserved in the transpeptidase domain
for all the pbp2b sequences (P417, E443, I460, G481 and A494)
obtained from the different bL
R clinical strains.
These results suggest that these substitutions could be
responsible for the fitness cost detected in the pbp2b mutants.
The pbp2b sequences of mutants constructed in the Cp1015 strain
were identical to those obtained from the clinical strains, with each
pbp2b sequence being coincident with the original pbp2b from the
clinical strains used to transform the wild-type strain. Hereafter,
the strain reference will be expressed as superscripts in the pbp
mutations; for example, the pbp2b mutation from strain Cba-28
that was transformed into the Cp1015 strain will be indicated as
pbp2b
28.
Fitness cost compensation between pbp mutations
associated to b-lactam resistance
All findings about compensation of growth alterations were
similar to the results obtained by competitive fitness assays in vitro,
when comparing the bL-susceptible Cp1015 strain with isogenic
pbp mutants. The compensatory effect among pbp mutations was
evident not only in triple, but also in pbp2b
19 pbp1a
19, pbp2b
19
pbp2x
19, pbp2b
28 pbp1a
28, and pbp2b
9V3 pbp2x
9V3 double mutants,
recovering their values of relative fitness of 0.95–1.10 in the case of
the triple pbp mutants (Table 1). We also observed that single pbp1a
mutations obtained from Cba-19 and Cba-28 increased fitness in
the wild-type strains (Table 1), and therefore should be considered
as increasing-fitness mutations. Interestingly, we found a direct
correlation between fitness compensation and an increase in the
spectrum and level of bL resistance (Fig. 1; Table 1).
The acquisition of pbp2x and pbp1a mutations from clinical bL
R
strains other than Cba-28 was also able to compensate the fitness
cost found in pbp2b
28 mutants. We observed that fitness cost was
ameliorated in 7 of the 8 double pbp2b
28 pbp2x mutants analyzed,
which were constructed by transforming pbp2x genes from donor
bL
RstrainsdifferentfromCba-28intothepbp2b
28mutant(TableS2
in Supporting Information S2). When the transpeptidase regions of
pbp2x sequences from the different mutants constructed in Cp1015
were compared, we observed that the pbp2x sequences in 4 mutants
Author Summary
For many years, pneumococcal infections have been
usually treated with b-lactams. However, the rapid
emergence of b-lactam resistance has complicated the
antimicrobial treatment of these infections in the last two
decades. The emergence and stability of antibiotic
resistance is a complex biological process driven by
different factors, such as the volume of antibiotic used.
Furthermore, many studies on the effect of a reduction in
b-lactam consumption have reported a sustained resis-
tance level to S. pneumoniae, suggesting that other factors
contribute to the persistence of b-lactam resistance. By
horizontal gene transfer, S. pneumoniae is able to acquire
genes from resistant strains or the commensal streptococ-
ci, which confer b-lactam resistance. Here, we show that
when certain resistance genes are acquired individually, an
important cost results in the bacterial fitness. However,
some clinical strains which have acquired genes that
increase b-lactam resistance can also compensate the
fitness cost imposed by this resistance, thereby producing
a selective advantage and raising the potential spreading
of b-lactam resistance. We suggest that pbp1a and pbp2x
mutant alleles are acquired for their compensatory effect
on fitness in addition to their contribution in developing
higher b-lactam resistance levels, and that this process
may occur even in the absence of antibiotics.
Fitness Compensation and b-Lactam Resistance
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28 pbp2x
12, pbp2b
28 pbp2x
52, pbp2b
28 pbp2x
54 and pbp2b
28
pbp2x
62) presented 10 conserved substitutions compared with
Cp1015, with the exception of pbp2x
52, which showed D278 in
place of N278(Fig. S5 in Supporting InformationS1).Coincidently,
pbp2x
52 was the only one of these 4 pbp2x alleles that could not
ameliorate the fitness cost of pbp2b
28 (Table S2 in Supporting
InformationS2).This result suggeststhat the N278residue might be
involved in the compensatory mechanism of fitness, at least for the
set of mutations present in pbp2x
12, pbp2x
54 and pbp2x
62. Each pbp2x
sequence used to transform Cp1015 was identical to the original
pbp2x obtained from clinical strains (data not shown).
To corroborate the fitness compensation of pbp mutations
observed in vitro, we also evaluated the relative fitness in vivo of
single, double and triple pbp mutants using a model of intraperi-
tonealinfectioninC57BL/6mice.Duetothe fact thatCp1015 isan
avirulent strain, we transferred the pbp mutations into the D39
strain, a virulent capsulated strain, which is able to infect C57BL/6
mice [14]. Single pbp mutants were obtained in D39 as described for
Cp1015. Curiously, however, only crossed double and triple pbp
mutants were recovered by transformation of the pbp2x and pbp1a
genes from the Cba-19 strain into the D39 pbp2b
9V3 mutant
(Table 1), indicating that the bL resistance conferred by these pbp
mutations was dependent on the genetic background of the
recipient strain. In agreement with the data obtained by assays in
vitro,weobserved asimilar compensatoryphenomenonforthe D39
pbp mutants in a mice model, with values of relative fitness of 0.27
for pbp2b
9V3, 0.80 for pbp2b
9V3 pbp2x
19, and 1.14 for the triple
pbp2b
9V3 pbp2x
19 pbp1a
19 mutant being obtained (Table 1).
bL resistance is complex and it has been reported that is
conferred by mosaic DNA fragments containing several mutations
in the transpeptidase domain, which decrease the binding of bLs.
With the purpose of identifying the amino acid substitutions that
could be involved in the fitness compensation mechanism
described, sub-parts of the pbp2x and pbp1a genes from the bL
R
Table 1. Relative competitive fitness of Streptococcus pneumoniae pbp mutants.
pbp mutants Relative fitness in vitro
a,b MIC (mg/ml)
Mean SD (95% CI) PIP CEF PEN
strain CP1015 0.015 0.015 0.02
pbp2b
19 0.77 0.02 0.74–0.80 0.2 0.015 0.02
pbp1a
19 1.10 0.06 1.04–1.18 0.015 0.15 0.02
pbp2x
19 0.98 0.05 0.90–1.06 0.015 0.15 0.02
pbp2b
19, pbp1a
19 1.02 0.04 0.96–1.08 0.2 0.15 0.15
pbp2b
19, pbp2x
19 1.06 0.04 0.99–1.12 0.2 0.15 0.15
pbp2b
19 pbp2x
19 pbp1a
19 0.95 0.05 0.87–1.03 0.2 0.2 0.3
pbp2b
28 0.65 0.02 0.62–0.68 0.2 0.015 0.02
pbp1a
28 1.05 0.05 1.03–1.12 0.015 0.12 0.02
pbp2x
28 0.97 0.04 0.90–1.03 0.015 0.15 0.02
pbp2b
28, pbp1a
28 1.03 0.04 0.97–1.09 0.2 0.12 0.02
pbp2b
28 pbp2x
28 0.86 0.01 0.84–0.87 0.2 0.15 0.15
pbp2b
28 pbp2x
28 pbp1a
28 1.10 0.04 1.04–1.16 0.2 0.2 0.15
pbp2b
9V3 0.65 0.04 0.59–0.71 0.18 0.015 0.02
pbp2x
9V3 0.80 0.04 0.74–0.86 0.015 0.12 0.02
pbp2b
9V3, pbp2x
9V3 1.08 0.04 1.02–1.14 0.18 0.12 0.2
pbp2b
9V3, pbp2x
9V3, pbp1a
9V3 1.10 0.05 1.02–1.18 0.18 0.12 0.3
pbp2b
28, pbp1a
28/A2 0,96 0.05 0,83–1.08 0.2 0.12 0.1
pbp2b
28 pbp1a
28/A3 0,70 0.05 0,58–0.82 0.2 0.15 0.04
pbp2b
28 pbp2x
28/X4 0,64 0.05 0,52–0.76 0.2 0.15 0.1
strain D39
D39 pbp2b
9V3 0.61 0.01 0.59–0.63 0.18 0.015 0.02
D39 pbp2b
9V3 pbp2x
19 0.75 0.05 0.67–0.83 0.18 0.15 0.15
D39 pbp2b
9V3 pbp2x
19 pbp1a
19 1.10 0.02 1.07–1.13 0.18 0.2 0.15
pbp mutants Relative fitness in vivo
b: MIC (mg/ml)
Mean SD (95% CI) PIP CEF PEN
D39 pbp2b
9V3 0.27 0.09 0.19–0.35 0.18 0.015 0.02
D39 pbp2b
9V3 pbp2x
19 0.80 0.1 0.70–0.89 0.18 0.15 0.15
D39 pbp2b
9V3 pbp2x
19pbp1a
19 1.14 0.2 0.95–1.33 0.18 0.2 0.15
aRelative competitive fitness is given by the ratio of the number of generations of the resistant and susceptible CP1015 strains.
bRelative fitness in vitro and in vivo was determined as described in Material and Methods.
References: SD, standard deviation; CI, confidence intervals; 9V3, Spain
9V-3 international clone; CEF, cefotaxime; PIP, piperacillin; PEN, penicillin.
doi:10.1371/journal.ppat.1002000.t001
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S6 and S7 in Supporting Information S1), and PCR products were
independently transformed into the pbp2b
28 mutant, with the
transformants being selected by cefotaxime resistance. We showed
that fragments A2, A3 (both amplified from pbp1a
28) and X4
(amplified from pbp2x
28) conferred resistance, but only A2 could
also compensate the fitness alterations (Table S3 in Supporting
Information S2), reaching the same level as that obtained when
pbp2b
28 was transformed with the pbp1a
28 fragment containing the
glycosyltransferase and transpeptidase domains (Table 1). We
analyzed the amino acid sequences deduced from the DNA
sequences of A2 and A3, and found four substitutions shared
between both regions (Fig. S8 in Supporting Information S1),
which are probably involved in bL resistance. Interestingly, the
E285Q mutation, localized in the transpeptidase domain [15], was
only present in A2 (from pbp1a
28). We propose that the E285Q
mutation may have contributed to the fitness compensation
mechanism. The presence of all these mutations was found in the
double mutants pbp2b
28 pbp1a
28 and pbp2b
28 pbp2x
28 constructed in
the Cp1015 genetic background as well as in the clinical Cba-28
strain.
In contrast with our results, Trzcinski and coworkers [12]
reported that the fitness cost of pneumococcal penicillin-resistant
strains increased with the number of resistant pbp alleles acquired.
On comparing the predicted amino acid sequences of the pbp
alleles studied here with those obtained by Trzcinski and
coworkers, we found clear differences between them, detecting
9, 11 and 12 substitutions in PBP2x, PBP1a and PBP2b,
respectively (Figs. S9, S10 and S11 in Supporting Information
S1). This suggests that the discrepancy found between these works
may be due to specific pbp mutations.
Cell division alterations associated to pbp mutations
It is known that PBPs are responsible for peptidoglycan
synthesis. These proteins form the main component of the cell
wall, and are involved in longitudinal wall growth and the cell
division process. Morlot and coworkers [16] have proposed
certain functions for PBP2b, PBP2a and PBP1a in S. pneumoniae,
but the specific roles of PBPs in the growth and division phases
are not yet well understood in bacteria. PBPs are also recognized
as the targets for bLs, the most frequently used antimicrobials for
treating bacterial infections. Therefore, considering that the
interaction between drug resistance and the cell division
processes remains unclear [4], we decided to investigate this
connection. First, we examined the effects of pbp mutations on S.
pneumoniae cell morphology, and then the putative cell division
alterations. Microscopic examinations of single pbp1a
28 and
pbp2x
28 mutants in Cp1015 strain did not display any morpho-
logical alterations, whereas the pbp2b
28 mutant (Fig. 2A) and all
10 strains bearing pbp2b mutations from clinical strains showed a
rod shape (data not shown). This atypical phenotype was also
found for pbp2b mutants with a different genetic background to
that of Cp1015, such as the R6 and D39 laboratory strains (data
not shown).
Curiously, 46% of pbp2b
28 cells had a rod-like shape (Fig. 2A),
with the rest showing an apparent wild-type morphology. Electron
microscopy revealed that the coccoid-shaped cells exhibited a
variety of cell wall defects, including an abnormal septum position,
atypical intracellular structures and frequent asymmetrical divi-
sions (Figs. 3 and S13 in Supporting Information S1) compared
with the wild-type strain (Figs. 3 and S12 in Supporting
Information S1), with the rod-shaped cells exhibiting multiple
septa (Figs. 3 and S13 in Supporting Information S1). Moreover,
the double pbp2b
28 pbp2x
28 mutant displayed a coccoid morphol-
ogy but with atypical septum localizations and peptidoglycan
accumulation (Figs. 3 and S14 in Supporting Information S1).
However, the triple pbp mutants had wild-type cell morphology
and showed no ultrastructural alterations (Figs. 3 and S15 in
Supporting Information S1).
When cells were stained with fluorescein-labeled vancomycin
(Van-FL), which localizes to sites of nascent peptidoglycan
synthesis and clearly marks the septum location in the wild-type
strain [17] (Fig. S16 in Supporting Information S1), an abnormal
septum pattern was revealed in rod-shaped cells of the pbp2b
28
mutants, suggesting a clear alteration in cell division (Fig. 4).
However, this phenomenon was compensated in the double
(pbp2b
28 pbp2x
28 or pbp2b
28 pbp1a
28) and triple pbp mutants (Fig. 4).
The morphological variation was confirmed by flow cytometry
analysis, which allowed determining the population distribution of
pneumococci by cell size. These assays showed a displacement
favoring a larger cell size in the pbp2b
28 mutant, and the
restoration of normal size in the triple pbp mutant (Fig. 2B). These
results suggest that the septal alterations and the cellular
enlargement found in the pbp2b
28 mutant could have been
responsible for its growth retardation.
To investigate the putative cause of these effects on cell
morphology and fitness, we analyzed the stability of the proteins
encoded by these pbp mutated genes using immunoblotting and
inhibiting the protein synthesis by the addition of kanamycin. For
these assays, we constructed C-terminal HA tagged PBPs to permit
Figure 1. Correlation plot between the fitness value of pbp mutants, obtained by using pbp genes from Cba-19 and Cba-28 clinical
strains, and the penicillin MIC increase found (mg/ml). A) Correlation for Cp1015 pbp
19 mutants, Cp1015 pbp2b
19 (diamonds), Cp1015 pbp2b
19
pbp2x
19 (triangles), and Cp1015 pbp2b
19 pbp1a
19 pbp2x
19 (circles). B) Correlation for Cp1015 pbp
28 mutants, Cp1015 pbp2b
28 (diamonds), Cp1015
pbp2b
28pbp2x
28 (triangles), and Cp1015 pbp2b
28 pbp2x
28 pbp1a
28 (circles).
doi:10.1371/journal.ppat.1002000.g001
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antibody. The gene constructs were inserted into the chromosome
by insertion-duplication as described previously [18], and these
genes were expressed as single copies under the control of their
native promoters. These pbp-HA mutants showed the same
phenotypes as the original pbp mutants, as well as the
compensatory effects demonstrated in the double and triple pbp
mutants (data not shown). We observed an increase in the half-life
(.120 min) for PBP2b
28 compared with the wild-type protein
(21 min), not only in pbp2b
28 (Fig. 5A) but also in the triple pbp
mutant (Fig. 5C). Interestingly, we also detected an increased half-
life for PBP1a
28 (.120 min) and PBP2x
28 (77 min) in the triple pbp
mutant compared with half-life of PBP1a (31 min) and PBP2x
(29 min) displayed in the wild-type strain (Figs. 5B and 5C). Our
hypothesis is that these stability changes in the PBP mutants could
have been responsible for the fitness/morphological alterations in
the pbp2b mutant and the compensatory effects in the triple pbp
mutant, and this will be discussed later.
We also investigated the putative cause of a morphological
change in the pbp2b
28 mutant, and particularly in the cell division
process. It was previously proposed that the life cycle of bacterial
cells consists of repeated controlled enlargement, septum forma-
tion, and cell division [19]. In this scenario, FtsZ is an essential
protein, which was postulated as the force generator that drives the
cell division process, since the correct localization of all proteins
involved in this mechanism is dependent on FtsZ [19,20]. To
evaluate the impact of pbp mutations on cell division, we
determined the FtsZ localization by immunofluorescence micros-
copy, using a polyclonal antibody against FtsZ. Before septum
formation, the FtsZ division ring has been described to be
localized at the mid cell, as we also observed for the wild-type
strain (Fig. 6A). However, an atypical FtsZ placement was found in
pbp2b cells, with an apparent helical structure rather than the mid-
cell localization found in wild-type cells. In the pbp2b
28 pbp2x
28
mutants, although we observed a coccoid morphology, the FtsZ
localization was still altered. In contrast, a total FtsZ placement
restoration was found in the triple pbp mutants (Fig. 6A). The
higher stability of PBP2b
28 led us to speculate that this increased
protein level could also cause a delocalization of this protein
mutant. Therefore, we constructed the PBP2b-GFP and PBP2b
28-
GFP fusions, expressed ectopically from a multicopy plasmid, in
order to study their localization in S. pneumoniae cells. We observed
that PBP2b-GFP was localized equatorially in the wild-type strain
as described previously [16]. However, PBP2b
28-GFP revealed an
atypical helical distribution, similar to FtsZ in the pbp2b
28 mutant
(Fig. 6B), suggesting that PBP2b could interact with FtsZ. To
investigate this, we analyzed this putative interaction by using a
bacterial two-hybrid system (Bacteriomatch II, Stratagene),
confirming this hypothesis by the detection of a positive interaction
between PBP2b
28 (or PBP2b) and FtsZ, but not between PBP2b
28
(or PBP2b) and PBP2x. This served as a control of specificity in
addition to the positive and negative controls included in this
system (Fig. 7).
Discussion
Mutations associated with antibiotic resistance are known to
impose a fitness cost in several bacterial species. Nevertheless, this
physiological cost can be ameliorated by compensatory mutations
in the same altered gene or in others involved in the developed
resistance mechanism, thereby maintaining the same resistance
level [21]. This compensatory phenomenon can occur with or
without selective pressure. However, under antibiotic exposure,
only those mutations able to maintain the resistance level will be
selected, thus permitting the survival and persistence of resistant
strains [22].
Figure 2. Effect of pbp mutations on cell morphology. Cells were prepared for microscopy and stained with DAPI as described in Materials and
Methods (bar scale, 5 mm). (A) Merged phase-contrast and DAPI fluorescence image of the pbp mutants showing a bacillar morphology, contrasting
with the typical coccoid shape of the CP1015 (wt) strain. (B) Cell shape modifications of the cell populations detected by flow cytometry analysis.
Exponentially growing bacterial cells were injected into a flow cytometer and the results were analyzed with the WinMDI software. To compare
populations, the data for each strain were plotted on a two-dimensional graph (x-axis, forward scatter; y-axis, side scatter).
doi:10.1371/journal.ppat.1002000.g002
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considered primary bL resistance determinants that confer low-
level resistance, whereas pbp1a mutations are acquired later and
are responsible for increasing this level. In this work, only pbp2b
mutations were related to a significant fitness cost, indicating that
these mutations were a disadvantage when competing with wild-
type strains. This finding indicates that the pbp2b mutants were
only able to survive under antibiotic pressure due to their
resistance. However, in the absence of antibiotics, the only way
for these mutants to compete with wild-type strains is by
improving their fitness by acquisition of compensatory mutations.
In this work, one of the most important findings is that these
compensatory mutations are also responsible for an increase in bL
resistance. It is well known that the combination of pbp mutations
that confers bL resistance is very complex, and that pbp alleles have
DNA mosaics with mutations in the region that encodes the
transpeptidase domain. These DNA mosaics may differ by over
20% from DNA sequences from sensitive pbp genes and from each
other, resulting in changes in amino acid of more than 10% [23].
In this scenario with PBPs showing multiple mutations, it is very
difficult to distinguish those involved in resistance development
from the alterations caused by the natural evolution of the genes.
Therefore, the contribution of each mutation is unclear, with the
exception of a few conserved mutations in the transpeptidase
domains of PBPs. In an attempt to identify the amino acids
involved in the compensatory mechanism described here, different
fragments of pbp1a
28 and pbp2x
28 were transformed into the
pbp2b
28 mutant, and the resistance and fitness cost were evaluated.
Although two fragments from the pbp1a
28 gene were able to confer
resistance, only A2 compensated the fitness cost caused by the
pbp2b
28 mutation. The amino acid sequence deduced from the
DNA sequence of A2 revealed that the E285Q substitution might
be involved in the compensatory mechanism.
On the other hand, when pbp2x alleles from different clinical
strains were used to transform pbp2b
28, only one of them (pbp2x
52)
was unable to ameliorate the fitness cost of this mutant. Four pbp2x
alleles shared 9 substitutions compared with Cp1015, with the
exception of pbp2x
52, which differed in only 1 residue (D278 in the
place of N278). This result suggests that N278, present in the pbp2x
mutations that compensated the fitness cost of pbp2b
28, could be
also a compensatory mutation, at least in the set of mutations
described for pbp2x
12, pbp2x
52, and pbp2x
62.
Rieux and coworkers [11] studied the relationship between the
acquisition of penicillin resistance and virulence, and demonstrat-
ed that the single and double pbp2b pbp2x mutants lost virulence in
an intraperitoneal infection model in Swiss mice. After several
passages in mice, the pbp2x mutations showed stability. However,
for the pbp2b mutants, virulent revertants were recovered without
intragenic modifications, suggesting that extragenic compensatory
mutations were involved in this phenomenon. On the other hand,
Trzcinski and coworkers [12] reported a rise in the bL resistance
levels of the susceptible D39 strain, by the sequential transforma-
tion of the pbp genes obtained from clinical isolates. This event was
accompanied by an increase in the fitness cost of a triple pbp
mutant as determined by a rat nasal colonization model, but
without growth alterations occurring in vitro. However, in the
Trzcinski’s work, no fitness compensation was detected among the
pbp mutations obtained from isolates belonging to the Spain
6B-2,
Hungary
19A-6, or serotype-9V Spain
9V-3 international clones.
In contrast with these reports, we showed that pbp2x and pbp1a
genes carrying specific mutations that conferred bL resistance, not
only compensated the pbp2b-associated fitness cost in Cp1015 and
D39 strains, but also increased the bL resistance levels. We also
demonstrated that this that this compensatory mechanism was
present in the clinical strains that belonged to the new serotype-14
variant of the Spain
9V-3 pneumococcal clone identified in
Argentina [13]. Related to this, several other studies have reported
that the fitness cost associated to antibiotic resistant mutants
depends on the specific mutations related to the resistant
mechanism and the genetic background [5,24,25,26,27,28]. Here,
we also used strain D39, the same strain used by Trzcinski and
coworkers [12], as an acceptor for pbp transformations. However,
contrasting results were obtained, which might be explained by
considering the different nature of the pbp mutations and the
particular evolution of the clinical isolates carrying these
mutations. These assumptions were supported by an amino acid
sequence analysis of the PBPs encoded by the mutated pbp2b,
pbp1a and pbp2x genes from the clinical strains used in this study,
with and a clear difference being found with those described by
Trzcinski and coworkers [12].
When the bL resistance of the double and triple pbp mutants was
analyzed, we found an increase not only in its level, but also in its
spectrum. We postulate a direct correlation between an increase in
bL resistance and fitness cost compensation. A similar mechanism
was previously shown for fluoroquinolone resistance, by analyzing
the parC/E and gyrA mutations obtained from clinical pneumo-
coccal strains using competitive fitness assays in vitro [8]. Recently,
this phenomenon was also described for fluoroquinolone resistance
in E. coli by fitness assays in vitro and in vivo using a laboratory
strain [28].
Figure 3. Electron microscopy analysis of cell morphology of
pbp mutants. Microphotographs of the wild-type strain (Cp1015)
revealed the typical morphology of S. pneumoniae, with a correct
septum placement, division and symmetry of daughter cells. In the
pbp2b
28 mutant, two subpopulations were identified, namely rod-like
and coccoid cells. The rod-like shaped cells showed multiple septa with
incorrect formation and placement. The coccoid-shape cells exhibited
multiple septa and intracellular accumulation of the cell wall, with the
atypical septum localization resulting in irregular cell divisions and
asymmetrical daughter cells (see arrows). The pbp2b
28 pbp2x
28 mutant
partially restored the coccoid morphology, but conserved some cell
alterations similar to those of the single pbp2b
28 mutant. The triple pbp
mutant showed a similar morphology to wt cells. Additional micropho-
tographs are shown in Figs. S12, S13, S14 and S15 in Supporting
Information S1 (bar scale, 1.6 mm).
doi:10.1371/journal.ppat.1002000.g003
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compensatory evolution associated to the pbp mutations that
conferred bL resistance, it is important to highlight another topic
linked to PBPs, the cell division process. In particular, we studied
the putative mechanism that caused morphological changes in
pbp2b mutants. It is already known that PBPs play an important
role in cell wall synthesis [29], but morphological alterations have
not been previously described for pbp mutants in the absence of b-
lactams. In this work, we described an atypical transition from a
coccoid to a rod-like shape and also other alterations caused by
pbp2b mutated genes obtained from bL
R clinical isolates, with this
morphological phenotype being reproduced in different laboratory
strains. In a previous work, it was proposed that PBP2b, an
essential class-B PBP, is involved in peripheral peptidoglycan
synthesis in S. pneumoniae [16]. Related to this, bacterial cell
morphogenesis is regulated by a controlled peptidoglycan
Figure 4. Septal localization in pbp mutants. Exponentially grown cells were stained with DAPI and fluorescent vancomycin (Fl-Van, which
labels nascent peptidoglycan synthesis and strongly marks septal localization) and analysed by using an epifluorescence microscope (see Material
and Methods). The pbp2b showed a septal accumulation in rod-like shaped cells, whereas the double (pbp2b pbp2x or pbp2b pbp1a) and the triple
pbp mutants restored their septal localization. Representative images are shown from experiments that were repeated independently three times
(bar scale, 1 mm).
doi:10.1371/journal.ppat.1002000.g004
Figure 5. Stability in vivo of wild-type and mutant PBPs. Strains Cp1015 (Panel A), Cp1015 pbp2b
28 (Panel B) and Cp1015 pbp2b
28pbp2x
28
pbp1a
28 (Panel C) expressing HA-tagged PBPs were grown in Todd Hewitt broth with 0.5% Yeast Extract to an OD600 nm of 0.2 prior to the addition of
kanamycin (500 mg/ml) to inhibit protein synthesis. At the time intervals indicated, aliquots were withdrawn and analyzed by SDS-PAGE followed by
immunoblotting with an anti-HA monoclonal antibody (see Material and Methods).
doi:10.1371/journal.ppat.1002000.g005
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progression of this process [30], and also by an orchestrated
interaction of cytoskeleton proteins triggered by FtsZ polymeriza-
tion [31]. The septal accumulation observed by Van-FL staining
in the pbp2b mutants indicated an abnormal cell division. To
investigate the impact of pbp2b mutations on this process, we
analyzed the FtsZ localization by immunofluorescence in the pbp2b
mutant and found an unusual localization pattern, revealing
structures that resembled the helical Van-FL-stained sidewall
shown by Bacillus subtilis [17]. To search for the reason why the
pbp2b mutants showed these morphological alterations, we also
measured the stability of PBP2b
28 and found that PBP2b
28 showed
an increased half-life, in contrast with that observed in the wild-
type strain. The fact that PBP2b
28 displayed a higher protein level
led us to investigate a putative delocalization of this protein in a
pbp2b
28 genetic background. Immunofluorescence assays showed
that PBP2b-GFP fusion localized equatorially as FtsZ did in the
wild-type strain described by Morlot and coworkers [16]. In
contrast, PBP2b
28-GFP fusion revealed an atypical helical
distribution similar to FtsZ in the pbp2b
28 mutant. It is possible
that protein-protein interactions may have altered the localization
of certain proteins, and we suspected that PBP2b
28 could have
interacted with FtsZ, thus modifying its normal emplacement.
Using a bacterial two-hybrid system, we demonstrated that FtsZ
was able to interact with PBP2b
28 as well as with the wild-type
protein, but not with PBP2x. Considering that PBP2b
28 was
delocalized, we propose that this interaction of PBP2b
28 with FtsZ
led to a misplacement of this protein, and consequently, to an
aberrant cellular morphology that caused a decreased fitness.
Moreover, these results support the idea that this interaction is
essential for the control of cell morphogenesis in S. pneumoniae,a s
suggested for E. coli [32,33]. In addition to this phenomenon, we
suspect that PBP2b
28 presented a decreased transpeptidase
activity, as all the PBP mutants confer bL
R by a decreased affinity
to these compounds [34,35]. Because PBP2b has been involved in
the elongation stage during cell division [16], we propose that as
PBP2b
28 could not elongate efficiently then these cells accumu-
lated septa, as demonstrated by Van-FL staining assays, and this
could be another cause of the morphological alterations found in
the pbp2b
28 mutant. In our laboratory, work is now in progress in
an attempt to gain a better understanding of this complex process
and this not well understood molecular mechanism.
To try to explain the putative cause of compensation of the
PBP2b
28 alterations by PBP1a
28 and PBP2x
28, we also analyzed
the stability of both mutant proteins. We observed that PBP1a
28
and PBP2x
28 displayed an increased half-life in the triple pbp
mutant as we had also for PBP2b
28. Considering that all these
PBPs have transpeptidase activity, these results suggest that
PBP1a
28 and PBP2x
28 have a complementary function on
PBP2b
28, based mainly on their increased protein levels. We
propose that this event could have caused the compensatory effect
on fitness and the morphological alterations in the pbp2b
28 mutant.
In the current work, we reported compensatory extragenic
mutations that restored the fitness alterations imposed by
mutations related to bL resistance. Given that the fitness
compensation determined by assays in vivo and in vitro were
similar, our data suggest that the selection of fitter strains may
have taken place in the natural habitat of S. pneumoniae. This
phenomenon has an important clinical relevance, since these
compensated pbp mutants cannot only maintain but also increase
the bL resistance levels, in contrast with previous reports [22]. Our
results also indicate that clinical strains acquired those pbp
mutations which improved their resistance-associated fitness cost,
producing a clear competitive and selective advantage, and thus
raising the potential spreading of bL resistance. We think it is
probable that S. pneumoniae exploited its high transformability to
acquire the compensatory pbp mutations that are essential for its
persistence and dissemination. This idea is supported by the
experimental data, which indicated that the pbp mutants showed
no transformability alterations, and that the pbp mutants could be
selected at a transformation rate higher than 10
-2/mg of DNA, thus
demonstrating that compensatory mutations can be acquired in a
one-step transformation. If this compensatory evolution was due to
the sequential incorporation of adaptive mutations, then the
occurrence of this phenomenon may increase rapidly under
antibiotic pressure. Therefore, it is possible that certain mutations
were selected for their compensatory effect on fitness in addition to
their contribution in developing higher bL resistance levels.
It is known that the emergence and stability of antibiotic
resistance is a complex biological process, being driven by different
factors such as the volume of antibiotic used, the rate of resistant
mutant formation, the fitness cost imposed and the compensatory
mechanisms to improve that cost [22]. Many studies on the effect
of a reduction in b-lactam consumption have reported a sustained
resistance level to S. pneumoniae [22], suggesting that other factors in
addition to antibiotic exposition are contributing to the persistence
Figure 6. Protein localization in wild-type and pbp mutants by
fluorescence microscopy. A) Localization of FtsZ. Microphotographs
indicate the most common patterns of FtsZ localization through the cell
cycle for wt and pbp mutants. Polyclonal antibody against FtsZ was
used for its detection by immunofluorescence microscopy. In the
Cp1015 (wt) strain, FtsZ is localized at the equatorial ring and septum, In
Cp 1015 pbp2b
28, the patterns suggest FtsZ delocalization and cell cycle
disruption. The triple pbp mutant showed a wild-type FtsZ placement.
B) Localization of PBP2b
28-GFP. Microphotographs indicate the most
common patterns found for PBP2b localization through the cell cycle in
the wt and pbp2b
28 mutant. Representative images are shown from
experiments that were repeated independently three times (bar scale,
1 mm).
doi:10.1371/journal.ppat.1002000.g006
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compensatory mechanism seems to be an important factor,
favoring environmental long-term persistence and the spreading
of bL
R strains. Moreover, it is known that fitness compensation
improves the dissemination ability of resistant strains, an essential
trait that characterizes pneumococcal clones. However, we could
not show that this phenomenon was particularly associated to the
pbp genes for other successful international clones. As mentioned
above, fitness restoration has not been reported for pbp mutations
obtained from clinical strains that belong to the Spain
6B-2,
Hungary
19A-6, and serotype-9V Spain
9V-3 international clones
[12]. Nevertheless, we demonstrated that a compensatory
mechanism was present, at least in the new serotype-14 variant
of the Spain
9V-3 clone recently characterized in our laboratory
[13], and also in a serotype-9V reference strain of this clone
(ATCC 700671) isolated in France [36]. Therefore, this model
contributes to the understanding of bL resistance evolution in S.
pneumoniae.
Materials and Methods
Bacterial strains, growth conditions and susceptibility
testing procedures
The bacterial strains used in this work are listed in Table S1 in
Supporting Information S2. bL
R pneumococcal strains were
obtained from invasive infections of pediatric patients and
belonged to the Spain
9V-3 international clone [13]. Cells were
routinely grown at 37uC in Todd-Hewitt broth supplemented with
1% bovine serum albumin. For antimicrobial susceptibility testing,
strains were grown at 37uC in a 5% CO2 atmosphere on Mueller-
Hinton agar with 5% defibrinated sheep blood. Penicillin,
cefotaxime, and piperacillin MICs were determined by agar
dilution following a CLSI protocol [37].
PCR conditions and transformation assays
To amplify the transpeptidase region of the pbp1a, pbp2b, and
pbp2x genes by PCR, we used the F1a/R1a, F2b/R2b, and F2x/
R2x [13] primer pairs, respectively (Fig. S1 in Supporting
Information S1). The internal fragments of the pbp1a gene were
amplified and sequenced with the following primer pairs: Fa1/Ra1
(from position 94 to 234); Fa2/Ra2 (from position 599 to 1002),
Fa3/Ra3 (from position 881 to 1294), Fa4/Ra4 (from position 385
to 521) and Fa5-Ra5 (from position 476 to 629) (Fig. S6 in
Supporting Information S1). The internal fragments of the pbp2x
gene were amplified and sequenced with the following pair
primers: Fx1/Rx1 (from position 125 to 271), Fx2/Rx2 (from
position 238 to 370); Fx3/Rx3 (from position 320 to 469) and Fx4-
Rx4 (from position 445 to 738) (Fig. S7 in Supporting Information
S1). The internal fragments of the pbp2b gene were amplified and
sequenced with the following primer pairs: Fb1/Rb1 (from
upstream of pbp2b to 114); Fb2/Rb2 (from position 69 to 256);
Fb3/Rb3 (from position 217 to 439); Fb4/Rb4 (from position 374
to 557) and Fb5/Rb5 (from position 502 to downstream pbp2b)
(Fig. S17 in Supporting Information S1). The primers sequences
are detailed in Table S4 in Supporting Information S2. PCR
products were amplified using the following parameters: initial
denaturation at 94uC for 4 min, 30 cycles of denaturation at 94uC
for 45 s, annealing at 55uC for 30 s, elongation at 72uC for 1 min,
and a final extension at 72uC for 10 min. Chromosomal DNA was
isolated using the Wizard Genomic DNA purification kit
(Promega), following the manufacturer’s instructions. The PCR
products were amplified from chromosomal DNA and used to
genetically transform the Cp1015 and D39 strains as described
previously [38]. Transformants were selected on Mueller-Hinton
agar plates supplemented with 5% defibrinated sheep blood
containing 0.05 mg/ml piperacillin or 0.1–0.3 mg/ml cefotaxime.
Natural competence was performed as described previously (3).
Flow cytometry analysis
Strain Cp1015 and its respective pbp mutants were individually
grown to the mid-logarithmic phase in Todd-Hewitt broth at
37uC. Cells were then washed three times and resuspended in
PBS. In order to analyze cell shape modifications by flow
cytometry analysis, bacteria were injected into a FACS Aria.
Between 50,000 and 100,000 events were counted and analyzed
by using WinMDI software. To compare populations, the data for
each strain were plotted on a two-dimensional graph (x-axis,
forward scatter; y-axis, side scatter).
Figure 7. Bacterial two hybrid assay. The percentage of interaction is defined as the ratio between the number of cells co-transformed able to
grow in 3-AT selective medium and the total number of cells obtained in medium without 3-AT. The plasmid pair pBT-LGF2/pTRG-Gal11
(BacterioMatch II, Stratagene) was used as a positive control. A) Interaction of PBP2b
wt-FtsZ and PBP2b
28-FtsZ B) As negative controls, the following
plasmid pairs were used: pBT/pTRG carrying codifying sequences of non-interacting proteins, C (-); pBT-empty/pTRG-recombinant, to evaluate the
two-hybrid system auto-activation for the target proteins (-)/Autoactivation Target; pBT-PBP2b/pTRG-empty, as non-specific transcription activation
control mediated by PBP2b
wt or PBP2b
28, C (-)/Autoactivation Bait.
doi:10.1371/journal.ppat.1002000.g007
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Relative fitness was quantified as the average number of
surviving progeny of a particular genotype, and this was compared
with average number of surviving progeny of competing genotypes
after a single generation. The wild-type strain genotype was
normalized at wt=1 and the fitnesses of other genotypes were
measured with respect to that genotype [39]. The cost of a
resistance mutation was determined by direct competition against
the susceptible Cp1015 strain as described previously [7].
Individual strains were exponentially grown to an OD600 nm of
0.2 and cultures were diluted 2,000-fold. Mixed cultures
containing equivalent amounts of the Cp1015 and pbp mutant
cells (about 5610
4 CFU/ml) were incubated in antibiotic-free
medium for 6 h. These mixed cultures were then diluted 1,000-
fold to avoid the typical lysis of S. pneumoniae cultures at the
stationary phase, and cells were cultured for an additional 6 h.
The number of viable cells was determined at 0, 6 and 12 h by
plating serial dilutions of the culture on BHI agar with 5%
defibrinated sheep blood, containing 0.05 mg/ml piperacillin (for
pbp2b simple mutants), 0.1 mg/ml cefotaxime (for pbp double and
triple mutants), or with no antibiotic. The number of susceptible
cells was calculated by subtracting the number of resistant cells
from the total cell number revealed by the CFU counts of the
plates without drug. To determine the CFU numbers, the mean of
four counts was calculated. The number of generations of the
resistant and Cp1015 strains in the mixed culture was calculated
by using the following formula: (log B - log A)/(log 2), where A is
the number of CFU/ml at time zero and B is the number of CFU/
ml at the end of each cycle (6 h and 12 h). The relative fitness of
each strain was determined from the ratio of the number of
generations of the resistant strain and Cp1015. The mean of four
to nine replicate competition assays were determined. Statistical
tests were performed using Instat software.
Determination of relative fitness in vivo
These assays using a mice model were performed as described
previously [40], but with specific modifications for S. pneumoniae.
Seven male C57BL/6, 4 to 5 weeks old (obtained from Comision
Nacional de Energia Atomica, Ezeiza, Argentina), were inoculated
intraperitoneally (under isoflurane anesthesia) with a mix of equal
parts of D39 strain and an isogenic pbp mutant (1610
5 CFU) in
0.1 ml 50 mM glucose (in PBS). These mice were sacrificed by
CO2 asphyxiation after 2 days, and strains were recovered from
each homogenized liver by plating onto BHI agar containing
piperacillin, cefotaxime, or no antibiotic, as described above.
Relative fitness was determined from the ratio of the number of
generations of the resistant strains and strain D39. ANOVA
statistical tests were performed with Instat software.
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide to the Care and Use of
Experimental Animals published by the Canadian Council on
Animal Care. The experimental protocols performed were
reviewed and approved by the Ethic Committee of the Facultad
de Ciencias Quı ´micas, Universidad Nacional de Cordoba (Permit
number 15-07-68964). The Ethic Committee is constituted by the
following professors of the Facultad de Ciencias Quı ´micas-UNC:
Laura Chiapello, Claudia Sotomayor, Margarita Brin ˜on, Teresa
Scimonelli, Santiago Quiroga, Mariana Contin and Graciela
Granero. The protocols and the Animal Laboratory of our
Institute (CIBICI-CONICET, Argentina) obtained an Animal
Welfare Assurance from NIH, USA (Assurance number A5802-
01, see http://grants.nih.gov/grants/olaw/assurance/500index.
htm?Country=AR#GridTop).
All the clinical strains used in this work were provided by the
strain collection of the Centro de Estudios Avanzados en Pediatrı ´a
(Co ´rdoba, Argentina). The Ethics Committee declared in writing
that no formal ethical approval was needed to use these clinically
obtained materials, because the specimens were remnant from
patient samples of blood and nasopharyngeal swabs collected from
routine analysis in bacteriology laboratories of public hospitals,
and the data were analyzed anonymously.
Van-Fl staining
Pneumococcal strains were routinely grown to an OD600 nm of
0.2 in Todd-Hewitt broth. Samples were collected and incubated
with 2 mg/ml Van-FL (Molecular Probes) for 20 minutes at 37uC.
Cells were centrifuged, washed three times with PBS and fixed
with 3% paraformaldehyde. After several washes with PBS, cells
were spotted on glass slides, air dried, dipped in methanol at
220uC for 10 min, and allowed to dry at room temperature. The
cells were then stained with DAPI (Sigma) at a final concentration
of 0.2 mg/ml for 10 min before being observed, and images were
acquired using a Nikon Eclipse TE-2000 epifluorescence micro-
scope fitted with a Nikon Digital Sight DS-U1 camera. This was
performed using ACT-U software, and images were processed
with Adobe Photoshop CS version.
Electron microscopy
Cp1015 and the isogenic mutants pbp2b
28, pbp2b
28pbp2x
28, and
pbp2b
28pbp2x
28pbp1a were exponentially grown at 37uC in Todd-
Hewitt medium, and samples for electron microscopy were then
collected, centrifuged, and fixed with 4% formaldehyde-2%
formalin in 0.1 M cacodylate buffer for 1 hour at room
temperature. An additional fixation with 1% osmium tetroxide
in cacodylate buffer was carried out for 1 hour at room
temperature. These fixed cells were dehydrated using an
increasing concentration of acetone, and embedded in polymer-
ized Araldite at 60uC for 48 hours. Thin sections were obtained
using a JEOL JUM-7 microtome equipped with a glass or gem
grade diamond knife, and microphotography was performed with
a Zeiss LEO 906E microscope.
Immunolocalization of FtsZ protein
Exponentially growing cells (OD600 nm of 0.25) were fixed with
3% paraformaldehyde for 15 min at room temperature and
incubated for 45 min on ice. The fixed bacteria were washed three
times in PBS (pH 7.4) and resuspended in GTE (50 mM glucose,
20 mM Tris-HCl, 10 mM EDTA), with a freshly prepared
lysozyme solution in GTE being added to a final concentration
of 2 mg/ml. 10 ml samples were immediately distributed onto poly-
L-lysine microscope slides and air dried. The slides were dipped in
220uC methanol for 5 min, in 220uC acetone for 30 s, and then
allowed to dry completely. After rehydration with PBS, the slides
were blocked for 1 hour at 37uC with 2% bovine serum albumin
(Sigma) in PBS (BSA-PBS). Cells were then incubated with a 1:100
dilution in BSA-PBS of rabbit polyclonal anti-FtsZ antibody [41]
for 1 hour at 37uC. After washing 10 times with PBS, samples
were incubated with a fluorescein-conjugated secondary antibody
in PBS (Alexa Fluor 488, Molecular Probes) for 30 min at 37uCi n
the dark. After removing the secondary antibody by washing
samples several times with PBS, DAPI was added at a final
concentration of 0.2 mg/ml and the samples were incubated for
10 min at room temperature. Slides were washed again, allowed to
dry, and then mounted using Dako fluorescent mounting medium
(Invitrogen). The final slides were stored at 220uC for several
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epifluorescence microscope, and processed with Adobe Photoshop
CS version.
Construction of strains expressing GFP-PBP2b
The pbp2b gene was amplified from Cp1015 wt and Cba-28
clinical strains with primers F2bf and R2bf (Table S4 in
Supporting Information S2). The gfpmut3 gene was amplified from
the pCM18 [42] plasmid using the primer pair Fgfp3/Rgfp3
(Table S4 in Supporting Information S2) in order to obtain a gfp
copy under the control of the pneumococcal constitutive
promoter, Pc [43]. The pbp genes were cloned into pGEMT-easy
(Promega) and the gfpmut3 gene into pCRTOPO 2.1 (Invitrogen),
thereby generating the pGEM-pbp and pGFPTOPO plasmids,
respectively (Table S4 in Supporting Information S2). The pbp
genes were exscinded by XhoI digestion of pGEM-pbp and inserted
into the SalI-restricted pGFP-TOPO plasmid. The SalI site was
located in pGFP-TOPO upstream the transcription origin of
gfpmut3 and downstream the Pc. The resultant plasmid pGFP-
TOPO-pbp contained a pbp2b N-terminal fusion to the gfpmut3
gene under the control of Pc. This construction was then removed
from pGFP-TOPO-pbp by EcoRI digestion and inserted into the
same restriction site in the E. coli-S. pneumoniae shuttle vector
plasmid pAT18 [44]. The resultant vector was named pAT18pbp-
gfp, and was used to transform the wild-type strain (Cp1015) and
the Cp1015 pbp2b mutants. The transformant selection was made
in BHI agar plates supplemented with 5% blood sheep and
2.5 mg/ml erythromycin. All constructions were confirmed by
PCR and sequencing with the same primers used for the
amplification of each gene.
Construction of strains expressing HA-tagged PBPs
Insertion duplication mutagenesis was used to construct strains
expressing HA-tagged PBPs. Primer pairs F2btag/R2bHA,
F2xtag/R2xHA and F1atag/R1aHA (Table S4 in Supporting
Information S2) were designed to amplify approximately the last
300–400 bp of the pbp2b, pbp2x and pbp1a genes fused to the
sequence of the HA tag. The PCR products were cloned into the
XhoI and XbaI sites of plasmid pEVP3 [43], and the final
constructions (named pEVP32bHA, pEVP32xHA, pEVP31aHA)
were used to transform the strains Cp1015, Cp1015 pbp2b
28 and
Cp1015 pbp2b
28 pbp2x
28 pbp1a
28. Selection of the transformants
was made in BHI 5% sheep blood agar supplemented with
chloramphenicol (2 mg/ml). All constructions were confirmed by
PCR and sequencing with the external primers for amplified
regions, as mentioned above.
Protein stability analysis of PBPs
Protein expression was inhibited in exponentially growing
cultures in Todd Hewitt broth with 0.5% Yeast Extract (total
volume 400 ml) at an OD600nm of 0.2 by the addition of
kanamycin (500 mg/ml). One-hundred ml aliquots were with-
drawn at 0, 30, 60 and 120 min after the addition of the antibiotic.
Cells were immediately harvested, washed once with 1 ml of ice
cold PBS and resuspended in 400 ml of ice cold MQ water plus
Complete protease inhibitor cocktail (Roche), before being
subjected to five freeze-thaw cycles followed by sonication using
a Sonics VibraCell VCX130 sonicator (20 cycles, 30 s ON 30 s
OFF, 40% amplitude). To solubilize the membrane proteins,
100 ml of 5X RIPA buffer (250 mM Tris pH 7.4, 750 mM NaCl,
5%NP-40, 2.5% Sodium deoxycholate, 0.5% SDS) were added
and the samples were heated for 10 min at 95uC, and cell debris
was removed by centrifugation for 15 min at 20,000 g. The total
protein content was determined by using bicinchoninic acid assay
[45]. After sodium dodecyl sulfate-polyacrylamide gel electropho-
resis and transfer to nitrocellulose membranes of 25 mg of the
protein extract, the membranes were probed with a mouse anti-
HA primary antibody (1:2,000; Abacam) and with a goat anti-
mouse immunoglobulin G secondary antibody conjugated to
horseradish peroxidase (1:2,500; Invitrogen). Detection was
performed with an enhanced chemiluminescence substrate (Super-
Signal West Pico Chemiluminescent Substrate; Pierce) and
Hyperfilm CL film (GE) using exposures of between 1 and
10 min. Western Blot bands were quantified using the Gel-Pro
Analyzer v3.1 software and the half-life was calculated with Graph
Pad Prism v5.3 software.
Protein-protein interaction assays
The bacterial two-hybrid system BacterioMatch II (Stratagene)
was used to screen for interactions of PBP2b with FtsZ protein and
PBP2x. The pbp2b coding sequence was amplified by PCR with
the primer pair F2bdh/R2bdh (Table S4 in Supporting Informa-
tion S2) from the Cp1015 and Cba-28 strains, digested with XhoI/
BamHI and cloned into the XhoI/BamHI restricted bacterial two-
hybrid vector pBT. In addition, the coding sequences of ftsZ and
pbp2x were amplified by PCR with F2xdh/R2xdh, FftsZdh/
RftsZdh (Table S4 in Supporting Information S2), respectively,
digested with XhoI/BamHI or XhoI/BglII, in that order, and cloned
into the pTRG vector cleaved by XhoI/BamHI. The E. coli XL1
Blue MR, the BacterioMatch II Validation Reporter strain
(Stratagene), was co-transformed with the two plasmids. Growth
cultures of the clones on M9 minimal media agar plates containing
2.5 mM 3-amino-1,2,4-triazol (3-AT) and 10 mg/ml of strepto-
mycin were assessed according to the manufacturer’s instructions.
Supporting Information
Supporting Information S1 Supplemental Figures S1 through
S17.Figure S1Graphical representation ofthePBPgenes.Figure
S2 Effect of pbp mutations on growth curves. Figure S3 Natural
competence assay of pbp mutants. Figure S4 Amino acid
substitutions found in PBP2b proteins obtained from different
clinical strains. Figure S5 Aminoacid substitutionsfound inPBP2x
proteins obtained from different clinical strains. Figure S6
Graphical representation of the pbp1a gene. Figure S7 Graphical
representation of the pbp2x gene. Figure S8 Amino acid
substitutions found in the transpeptidase region of PBP1a
28 in the
pbp2b
28 pbp1a
28 mutant. Figure S9 Comparison of amino acid
sequences of PBP2b mutants. Figure S10 Comparison of amino
acid sequences of PBP2x mutants. Figure S11 Comparison of
amino acid sequences of PBP1a mutants. Figure S12 Electron
microscopy analysis of cellular morphology of strain Cp1015 (wt).
Figure S13 Electron microscopy analysis of the effect of pbp2b
mutations on cellular morphology. Figure S14 Electron micros-
copy analysis of the effect of pbp2b pbp2X mutations on cellular
morphology. Figure S15 Electron microscopy analysis of the effect
of pbp2bpbp2x pbp1a mutationson cellularmorphology.Figure S16
Peptidoglycan synthesis of strain Cp1015 (wt) at different stages in
the cell cycle. Figure S17 Graphical representation of the pbp2b
gene showing the different DNA fragments sequenced.
Found at: doi:10.1371/journal.ppat.1002000.s001 (PDF)
Supporting Information S2 Supplemental Tables S1 through
S4. Table S1 Bacterial strains and plasmids used in this work.
Table S2 Fitness cost analysis of double pbp2b pbp2x mutants
obtained with pbp2x genes from different clinical strains. Table S3
Contribution of internal fragments of pbp1a and pbp2x in resistance
and fitness compensation. Table S4 Primers used in this work.
Found at: doi:10.1371/journal.ppat.1002000.s002 (PDF)
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